500 million people suffer from asthma and COPD

Current inhalers are only up to 33% effective*

Shockingly many people get less than 10% of the correct dosage

We are developing a device that is over 90% effective

Group of over 60s on a hike through a field with a dog

In fact initial studies of the technology showed 94% of the inhaled dose was found in the systemic circulation.

This massive increase in efficiency, should lead to better treatment, reducing pressure on healthcare services, and most importantly improved quality of life for sufferers.

Not so small-print

*33% of the dispensed dose is reaching the target area of the lung. The rest is deposited in the mouth and upper airways where it is ineffective and can cause adverse effects like oral candidiasis.

Athos Medical Technology

+44 78 99 99 5295

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Decline Accept